Detalhe da pesquisa
1.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med
; 384(22): 2102-2114, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077643
2.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
N Engl J Med
; 384(14): 1289-1300, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616314
3.
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
Future Oncol
; 19(6): 413-426, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919916
4.
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer.
J Urol
; 206(4): 952-959, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34032505
5.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 21(1): 105-120, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753727
6.
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.
Prostate
; 79(14): 1683-1691, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442327
7.
Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies.
Oncologist
; 24(4): 549-554, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670598
8.
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease.
J Urol
; 202(6): 1199-1208, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31188734
9.
Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study.
Eur J Nucl Med Mol Imaging
; 46(5): 1092-1101, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547207
10.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.
Lancet
; 390(10109): 2266-2277, 2017 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28916371
11.
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib.
Oncologist
; 21(10): 1212-1217, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27382030
13.
Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel.
Prostate
; 74(4): 433-40, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24338986
14.
Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib.
Oncologist
; 19(1): 51-60, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24309979
16.
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors.
Isr Med Assoc J
; 16(6): 347-51, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25058995
17.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
J Clin Oncol
; 42(11): 1222-1228, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227898
18.
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study.
Nutrients
; 15(16)2023 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37630724
19.
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis.
Front Oncol
; 13: 1151701, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293597
20.
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram.
Oncologist
; 17(12): 1508-14, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22971522